Comparative Metabolomics and Network Pharmacology Study Reveals Chemopreventive Potential of Wild Soybean (Glycine soja)
Foods · 02.04.2026 · 15 (7) · 1209
DOI: 10.3390/foods15071209 ↗Kurz gefasst
Fachartikel in der Zeitschrift Foods, online erschienen am 02.04.2026. Verfasst von Meinan Sui und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Biology and Agriculture, Jiamusi University, Jiamusi 154007, China. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Heilongjiang Provincial Natural Science Foundation, Heilongjiang Provincial Department of Education Basic Scientific Research Operating Fund, Jiamusi University Doctoral Special Scientific Research Fund Startup Project.
Abstract (Originalsprache)
Wild soybean (Glycine soja), as the wild ancestor of cultivated soybean, serves as a rich reservoir of phytochemicals with significant potential in functional food applications and chemoprevention. However, its metabolic characteristics and health benefits remain to be systematically elucidated. In this study, non-targeted metabolomics technology was employed, in conjunction with network pharmacology and molecular docking analysis, to systematically investigate the metabolic differences between wild soybean seeds from three distinct ecological regions and cultivated soybean seeds. Metabolomic profiling revealed the unique metabolic characteristics of wild soybean, identifying 124 significantly upregulated metabolites and 7 unique compounds, with the most notable enrichment in flavonoids and prunolides. Network pharmacology analysis indicated that 22 key metabolites in wild soybeans were associated with 503 pan-cancer targets (covering breast, lung, and colorectal cancers), primarily regulating pathways related to “cancer” and “lipids and atherosclerosis.” Molecular docking experiments further confirmed the stable binding affinity of key bioactive components, including quercetin and L-arginine, with core targets such as TP53, TNF, EGFR, IL1B, and JUN. These findings elucidate the unique phytochemical profile of wild soybean and its potential multi-target chemopreventive mechanisms, providing theoretical support for developing it as a natural chemopreventive agent.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Biology and Agriculture, Jiamusi University, Jiamusi 154007, China.
- Heilongjiang Institute of Pharmacy, Jiamusi 154007, China.
- Key Laboratory of Microecology-Immune Regulatory Network and Related Diseases, School of Basic Medicine, Jiamusi University, Jiamusi 154000, China.
- College of Pharmacy, Jiamusi University, Jiamusi 154007, China.
Förderung
- Heilongjiang Provincial Natural Science Foundation
- Heilongjiang Provincial Department of Education Basic Scientific Research Operating Fund
- Jiamusi University Doctoral Special Scientific Research Fund Startup Project
- Heilongjiang Provincial Natural Science Foundation of China
Zitieren
APA
Sui, M., Yan, Z., Xu, L., Liu, D., Zhang, P., & Zhao, H. (2026). Comparative Metabolomics and Network Pharmacology Study Reveals Chemopreventive Potential of Wild Soybean (Glycine soja). Foods, 15(7), 1209. https://doi.org/10.3390/foods15071209
Vancouver
Sui M, Yan Z, Xu L, Liu D, Zhang P, Zhao H. Comparative Metabolomics and Network Pharmacology Study Reveals Chemopreventive Potential of Wild Soybean (Glycine soja). Foods. 2026;15(7):1209. doi:10.3390/foods15071209
BibTeX
@article{Sui2026,
author = {Sui, Meinan and Yan, Zixin and Xu, Long and Liu, Dejiang and Zhang, Pengxia and Zhao, Hong},
title = {Comparative Metabolomics and Network Pharmacology Study Reveals Chemopreventive Potential of Wild Soybean (Glycine soja)},
journal = {Foods},
year = {2026},
volume = {15},
number = {7},
pages = {1209},
doi = {10.3390/foods15071209}
}
EUVIMED